ONON:NYSE
On Holding AG
$28.36
0.00%
(0.00) 1D
$28.25
arrow_downward
-0.39% (-0.11)todayPre-market
Closed: Sep 3, 4:00:05 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONON...
Mkt. cap
1.09T
Avg. vol.
8.02M
Volume
24.48K
P/E ratio
19.47
52-wk high
$51.08
52-wk low
$27.56
EPS
$1.46
Beta
2.08
Shares outstanding
296.87M
No. of employees
4K
Mkt. cap
1.09T
Avg. vol.
8.02M
Volume
24.48K
P/E ratio
19.47
52-wk high
$51.08
52-wk low
$27.56
EPS
$1.46
Beta
2.08
Shares outstanding
296.87M
No. of employees
4K
News stories
From web sources and news partners
The Morning Call
·
1 hour ago
Eli Lilly pharmaceutical plant in Upper Macungie takes another step forward
Simply Wall Street
·
7 hours ago
Did On's (ONON) FP Movement Collab Reveal a Deeper Women’s Brand Strategy?
AD HOC NEWS
·
7 hours ago
Lam Research stock gains on record Q4 2026 revenue
The Motley Fool
·
17 hours ago
Great News for Eli Lilly Stock Investors
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About On Holding AG
CEODavid A. Ricks | Mark Mauer | Martin Hoffmann
Employees3.96K
Founded1876
HeadquartersIndianapolis, Indiana, United States
SectorFootwear
Websiteir.jd.com